{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:16:13Z","timestamp":1793470573307,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canlet.2025.217703","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:30:00Z","timestamp":1744871400000},"page":"217703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Multiplex characterization of circulating tumor cells from ductal carcinoma in situ patients suggests early tumor dissemination"],"prefix":"10.1016","volume":"623","author":[{"given":"Brittany","family":"Rupp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7492-7633","authenticated-orcid":false,"given":"Neha","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Thanasiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Tuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6772-6111","authenticated-orcid":false,"given":"Kirk","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean E.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-4569","authenticated-orcid":false,"given":"Justin","family":"Colacino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Wicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunitha","family":"Nagrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canlet.2025.217703_bib2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217703_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.canlet.2025.217703_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10549-017-4644-3","article-title":"Is invasion a necessary step for metastases in breast cancer?","volume":"169","author":"Narod","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.canlet.2025.217703_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1200\/JCO.21.01674","article-title":"Overcoming barriers in ductal carcinoma in situ management: from overtreatment to optimal treatment","volume":"40","author":"Wright","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217703_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17124","article-title":"Association of a diagnosis of ductal carcinoma in situ with death from breast cancer","volume":"3","author":"Giannakeas","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canlet.2025.217703_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.672195","article-title":"Early dissemination of circulating tumor cells: biological and clinical insights","volume":"11","author":"Chemi","year":"2021","journal-title":"Frontiers in oncology"},{"issue":"5","key":"10.1016\/j.canlet.2025.217703_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tips.2022.02.005","article-title":"Circulating tumor cells in precision medicine: challenges and opportunities","volume":"43","author":"Rupp","year":"2022","journal-title":"Trends in pharmacological sciences"},{"issue":"10","key":"10.1016\/j.canlet.2025.217703_bib9","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/ijc.25895","article-title":"Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ","volume":"129","author":"S\u00e4nger","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217703_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10549-011-1478-2","article-title":"Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast","volume":"131","author":"Banys","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.canlet.2025.217703_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-014-2898-6","article-title":"Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ","volume":"144","author":"Banys","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.canlet.2025.217703_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3333","article-title":"Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer","volume":"14","author":"Franken","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217703_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10549-017-4452-9","article-title":"Molecular characterization and heterogeneity of circulating tumor cells in breast cancer","volume":"166","author":"Jakabova","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2025.217703_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.672195","article-title":"Early dissemination of circulating tumor cells: biological and clinical insights","volume":"11","author":"Chemi","year":"2021","journal-title":"Frontiers in oncology"},{"issue":"9","key":"10.1016\/j.canlet.2025.217703_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrc3820","article-title":"Challenges in circulating tumour cell research","volume":"14","author":"Alix-Panabi\u00e8res","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"24","key":"10.1016\/j.canlet.2025.217703_bib15","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1158\/1078-0432.CCR-04-1110","article-title":"Circulating tumor cells in patients with breast cancer dormancy","volume":"10","author":"Meng","year":"2004","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2025.217703_bib16","series-title":"StatPearls","article-title":"Histology, white blood cell","author":"Tigner","year":"2022"},{"issue":"3","key":"10.1016\/j.canlet.2025.217703_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cels.2017.08.012","article-title":"High-throughput microfluidic labyrinth for the label-free isolation of circulating tumor cells","volume":"5","author":"Lin","year":"2017","journal-title":"Cell systems"},{"issue":"1","key":"10.1016\/j.canlet.2025.217703_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54960-y","article-title":"New labyrinth microfluidic device detects circulating tumor cells expressing cancer stem cell marker and circulating tumor microemboli in hepatocellular carcinoma","volume":"9","author":"Wan","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2025.217703_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/cancers12010127","article-title":"High-throughput label-free isolation of heterogeneous circulating tumor cells and CTC clusters from non-small-cell lung cancer patients","volume":"12","author":"Zeinali","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.canlet.2025.217703_bib22","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/s41588-022-01182-0","article-title":"The NALCN channel regulates metastasis and nonmalignant cell dissemination","volume":"54","author":"Rahrmann","year":"2022","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2025.217703_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41416-021-01327-8","article-title":"Detection of clustered circulating tumour cells in early breast cancer","volume":"125","author":"Krol","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217703_bib24","article-title":"Isolation of circulating biomarkers for Liquid biopsy using immunoaffinity-based stimuli-responsive hybrid hydrogel beads","volume":"1","author":"Kang","year":"2021","journal-title":"Anal. Sens."},{"key":"10.1016\/j.canlet.2025.217703_bib25","article-title":"TruSight Oncology 500: enabling comprehensive genomic profiling and biomarker reporting with targeted sequencing","author":"Zhao","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.canlet.2025.217703_bib26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ccell.2023.04.002","article-title":"A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression","volume":"41","author":"Hutten","year":"2023","journal-title":"Cancer Cell"},{"issue":"D1","key":"10.1016\/j.canlet.2025.217703_bib27","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217703_bib28","unstructured":"Catalogue of Somatic Mutations In Cancer. (n. d) https:\/\/cancer.sanger.ac.uk\/cosmic."},{"issue":"9","key":"10.1016\/j.canlet.2025.217703_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jnci\/djq101","article-title":"Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis","volume":"102","author":"Kerlikowske","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"7634","key":"10.1016\/j.canlet.2025.217703_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nature20609","article-title":"Mechanism of early dissemination and metastasis in Her2+ mammary cancer [published correction appears in Nature. 2017 Dec 13","volume":"540","author":"Harper","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217703_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41588-024-02060-7","article-title":"Mutations in healthy breast tissue","volume":"57","author":"Danovi","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2025.217703_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-08129-x","article-title":"Normal breast tissues harbour rare populations of aneuploid epithelial cells","volume":"636","author":"Lin","year":"2024","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.canlet.2025.217703_bib33","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jnci\/djg097","article-title":"Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy","volume":"95","author":"Kerlikowske","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2025.217703_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-020-06042-1","article-title":"Treating (low-risk) DCIS patients: what can we learn from real-world cancer registry evidence?","volume":"187","author":"Byng","year":"2021","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:01:49Z","timestamp":1760742109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525002691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"alternative-id":["S0304383525002691"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217703","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiplex characterization of circulating tumor cells from ductal carcinoma in situ patients suggests early tumor dissemination","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217703"}}